RT Journal Article
SR Electronic
T1 Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.03.21265791
DO 10.1101/2021.11.03.21265791
A1 Poukka, Eero
A1 Baum, Ulrike
A1 Palmu, Arto A.
A1 Lehtonen, Toni O.
A1 Salo, Heini
A1 Nohynek, Hanna
A1 Leino, Tuija
YR 2021
UL http://medrxiv.org/content/early/2021/11/04/2021.11.03.21265791.abstract
AB Recently, Covid-19 vaccine effectiveness has decreased especially against mild disease due to emergence of the Delta variant and waning protection. In this register-based study among healthcare workers in Finland, the vaccine effectiveness of two-dose mRNA vaccine series against SARS-CoV-2 infection decreased from 82% (95% CI 79-85%) 14-90 days after vaccination to 53% (43-62%) after 6 months. Similar trend was observed for other series. Waning was not observed against Covid-19 hospitalization. These results facilitate decision-making of booster doses for healthcare workers.Competing Interest StatementAAP is an investigator in studies for which the Finnish Institute for Health and Welfare has received research funding from Sanofi Pasteur, GlaxoSmithKline and Pfizer. All other authors declare no conflict of interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Under Finnish law, THL is the national expert institution in Finlnad to carry out surveillance on the impact of vaccinations (Communicable Diseases Act, https://www.finlex.fi/en/laki/kaannokset/2016/en20161227.pdf) and specific ethical approval was not needed. The supplements material includes THL Director of the Department for Health Security signatured statement considering the ethical review. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesBy Finnish law, the authors are not permitted to share individual-level register data. The computing code is available upon request.